ChiCTR2100042375已完成Unknown
Evaluation of Biomarkers for Prediction of Morbidity and Mortality in COVID-19 at a Tertiary Care Center in Pakistan
No1 个研究点 分布在 1 个国家目标入组 157 人开始时间: 2020年3月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 157
- 试验地点
- 1
- 主要终点
- 预后
研究概览
简要总结
To evaluate the association of Serum Procalcitonin and other biochemical markers including ferritin, CRP, IL-6 with severity in Coronavirus disease 2019 (COVID-19), hospitalized patients and to test the hypothesis that they are an independent predictor of mortality.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 100（—）
- 性别
- All
入选标准
- •both genders and aged 18 years and older groups with SARS-CoV-2 positive on a reverse-transcriptase polymerase chain reaction (PCR) test and received treatment at our center
排除标准
- •biochemical work up on admission not undertaken;
- •known thalassemic cases.
研究组 & 干预措施
Severe COVID
Nil
non-severe COVID
Nil
结局指标
主要结局
预后
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
This study will check if a blood test called procalcitonin can show how severe pneumonia is when patients are admitted. By measuring this level, we hope doctors can detect serious infection early, give timely treatment, and improve patient recovery.CTRI/2025/10/096697Sayanti Pattanayak100
进行中（未招募）
不适用
The Role of Inflammatory Biomarkers in Preventing Deep Sternal Wound Infections After SternotomyMediastinitisNCT07376070Levan Nebieridze30
尚未招募
不适用
Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular CarcinomaNCT07414433University of Belgrade60
尚未招募
不适用
Multiple Myeloma Extramedulary Disease Samples FFPENCT07354555BIWAKO15
招募中
不适用
Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular CarcinomaNCT07378709University of Belgrade15